retatrutide clinical results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide shows 30% weight loss
Description
2023;18:e979
GLP-1 receptor agonists function by mimicking a hormone that targets areas of the brain involved in appetite regulation
Bariatric surgery, on the other hand, goes beyond symptom management
Or worse, it drops a little, then
Start with a free consultation
Red flags to watch for Any provider who prescribes without a medical evaluation, doesnt require follow-up appointments, or only offers compounded medications without discussing FDA-approved alternatives
